Delivery Order SPE2DB25D3012-SPE2DB25FWZTC
- Not listed
- The Defense Logistics Agency awarded a $1,954.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of August 21, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a $1,030.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of August 19, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order valued at $14,315.65 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with performance in Conshohocken, Pennsylvania. This firm fixed price, non-set-aside contract was competitively awarded and is scheduled for completion by August 15, 2025. The award represents a single delivery order transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $15,548.40 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement through the federal medical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a $28,321.00 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of July 30, 2025. This competitive, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine supply, valued at $18,567.90 under a firm fixed price structure. This non-set-aside award was executed on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes valued at $9,034.57 under a firm fixed price contract type. The award was made on July 18, 2025, with an ultimate completion date of July 21, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $22,886.40 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine supply. This firm fixed price contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery...
- The Defense Logistics Agency awarded a $1,837.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 mcg/mL vaccine syringes on August 7, 2025, with an ultimate completion date of August 8, 2025. This non-set-aside contract was performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,751.90 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZTCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,920.10 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. This firm fixed price, competitively awarded contract was issued on September 2, 2025, with a completion date of September 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply procurement across the military healthcare system. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its comprehensive IDC with DLA to fulfill critical vaccine and medication needs for Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive portfolio demonstrates consistent capability to deliver a wide range of pharmaceutical products and medical supplies through competitive procurement processes. As a prime vendor under DLA's global pharmaceutical support program, AmerisourceBergen maintains the operational infrastructure necessary to support military medical requirements worldwide through flexible contract vehicles designed to streamline federal medical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 9/2/25 |